Our patient at risk from unauthorized, unapproved, illegally imported fake “generic medicines”
Indian J Med Sci
;
2018 SEP; 70(3): 43-47
Artigo
| IMSEAR
| ID: sea-196507
ABSTRACT
Introduction:
We came across patients inquiring with oncologists about cheap copy medicines. These were of recently licensedinnovator drugs that should have been available from original company holding their patents. In fact these copy medicines weremanufactured in our neighboring countries and made available in India. We investigated further and this manuscript puts together thestartling information that we were able to find regarding the thriving grey market for fake generic medicines.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Tipo de estudo:
Estudo de etiologia
Revista:
Indian J Med Sci
Ano de publicação:
2018
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS